Hide

FocusBar

Subscribe to Premium Member
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.006
UHS's Cash to Debt is ranked lower than
94% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 0.32 vs. UHS: 0.006 )
UHS' s 10-Year Cash to Debt Range
Min: 0.01   Max: 0.04
Current: 0.01

0.01
0.04
Equity to Asset -0.039
UHS's Equity to Asset is ranked lower than
99% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. UHS: -0.039 )
UHS' s 10-Year Equity to Asset Range
Min: -0.08   Max: 0.26
Current: -0.04

-0.08
0.26
Interest Coverage 5.3
UHS's Interest Coverage is ranked lower than
61% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. UHS: 5.3 )
UHS' s 10-Year Interest Coverage Range
Min: 5   Max: 11
Current: 5.3

5
11
F-Score: 5
Z-Score: 1.88
M-Score: -2.61
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 13.50
UHS's Operating margin (%) is ranked higher than
66% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. UHS: 13.50 )
UHS' s 10-Year Operating margin (%) Range
Min: 7.7   Max: 13.5
Current: 13.5

7.7
13.5
Net-margin (%) 6.4
UHS's Net-margin (%) is ranked higher than
55% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 3.85 vs. UHS: 6.4 )
UHS' s 10-Year Net-margin (%) Range
Min: 3.5   Max: 6.4
Current: 6.4

3.5
6.4
ROE (%) 16.3
UHS's ROE (%) is ranked higher than
54% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 11.20 vs. UHS: 16.3 )
UHS' s 10-Year ROE (%) Range
Min: 11.2   Max: 20
Current: 16.3

11.2
20
ROA (%) 5.4
UHS's ROA (%) is ranked lower than
56% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 4.60 vs. UHS: 5.4 )
UHS' s 10-Year ROA (%) Range
Min: 3.1   Max: 8.4
Current: 5.4

3.1
8.4
ROC (Joel Greenblatt) (%) 24.30
UHS's ROC (Joel Greenblatt) (%) is ranked higher than
53% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 17.40 vs. UHS: 24.30 )
UHS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 13.6   Max: 24.3
Current: 24.3

13.6
24.3
Revenue Growth (%) 7.7
UHS's Revenue Growth (%) is ranked higher than
93% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 4.50 vs. UHS: 7.7 )
UHS' s 10-Year Revenue Growth (%) Range
Min: 6.4   Max: 12.8
Current: 7.7

6.4
12.8
EBITDA Growth (%) 14.8
UHS's EBITDA Growth (%) is ranked higher than
95% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 4.70 vs. UHS: 14.8 )
UHS' s 10-Year EBITDA Growth (%) Range
Min: 1.5   Max: 19.3
Current: 14.8

1.5
19.3
EPS Growth (%) 14.5
UHS's EPS Growth (%) is ranked higher than
91% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. UHS: 14.5 )
UHS' s 10-Year EPS Growth (%) Range
Min: -0.4   Max: 22.5
Current: 14.5

-0.4
22.5
» UHS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2012

UHS Guru Trades in Q2 2012

Steven Cohen 153,588 sh (+252.04%)
Joel Greenblatt 40,605 sh (+0.72%)
Chris Davis 284,300 sh (+0.07%)
Vanguard Health Care Fund 4,120,800 sh (unchged)
Louis Moore Bacon Sold Out
Private Capital 948,369 sh (-1.14%)
Westport Asset Management 1,568,200 sh (-4.27%)
Paul Tudor Jones 47,900 sh (-6.81%)
Andreas Halvorsen 4,178,470 sh (-8.98%)
Jim Simons 131,800 sh (-42.01%)
» More
Q3 2012

UHS Guru Trades in Q3 2012

Jean-Marie Eveillard 898,114 sh (New)
Manning & Napier Advisors, Inc 248,300 sh (New)
Steven Cohen 335,135 sh (+118.2%)
Joel Greenblatt 57,186 sh (+40.83%)
Chris Davis 284,300 sh (unchged)
Jim Simons Sold Out
Paul Tudor Jones Sold Out
Vanguard Health Care Fund 4,020,800 sh (-2.43%)
Private Capital 887,219 sh (-6.45%)
Westport Asset Management 1,324,213 sh (-15.56%)
Andreas Halvorsen 2,975,594 sh (-28.79%)
» More
Q4 2012

UHS Guru Trades in Q4 2012

Manning & Napier Advisors, Inc 2,591,290 sh (+943.61%)
Steven Cohen 356,108 sh (+6.26%)
Jean-Marie Eveillard 922,998 sh (+2.77%)
Westport Asset Management 1,174,213 sh (unchged)
Vanguard Health Care Fund 4,020,800 sh (unchged)
Chris Davis 271,300 sh (-4.57%)
Private Capital 801,341 sh (-9.68%)
Joel Greenblatt 48,209 sh (-15.7%)
Andreas Halvorsen 2,106,894 sh (-29.19%)
» More
Q1 2013

UHS Guru Trades in Q1 2013

Ron Baron 200,790 sh (New)
Andreas Halvorsen 2,625,972 sh (+24.64%)
Joel Greenblatt 54,597 sh (+13.25%)
Westport Asset Management 1,165,268 sh (-0.76%)
Vanguard Health Care Fund 3,873,600 sh (-3.66%)
Chris Davis 251,300 sh (-7.37%)
Private Capital 699,605 sh (-12.7%)
Jean-Marie Eveillard 630,691 sh (-31.67%)
Steven Cohen 223,995 sh (-37.1%)
Manning & Napier Advisors, Inc 1,197,493 sh (-53.79%)
» More
» Details

Insider Trades

Latest Guru Trades with UHS

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Andreas Halvorsen 2013-03-31 Add 24.64%0.2%$48.35 - $64.38 $ 67.0418%2625972
Ron Baron 2013-03-31 New Buy0.07%$48.35 - $64.38 $ 67.0418%200790
Jean-Marie Eveillard 2013-03-31 Reduce -31.67%0.05%$48.35 - $64.38 $ 67.0418%630691
Andreas Halvorsen 2012-12-31 Reduce -29.19%0.28%$41.31 - $49.46 $ 67.0449%2106894
Andreas Halvorsen 2012-09-30 Reduce -28.79%0.43%$38.17 - $45.75 $ 67.0463%2975594
Jean-Marie Eveillard 2012-09-30 New Buy0.15%$38.17 - $45.75 $ 67.0463%898114
Joel Greenblatt 2012-09-30 Add 40.83%0.05%$38.17 - $45.75 $ 67.0463%57186
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry
vs
history
P/E(ttm) 15.10
UHS's P/E(ttm) is ranked higher than
80% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 16.20 vs. UHS: 15.10 )
UHS' s 10-Year P/E(ttm) Range
Min: 8.02   Max: 37
Current: 15.1

8.02
37
P/B 2.40
UHS's P/B is ranked lower than
54% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 1.99 vs. UHS: 2.40 )
UHS' s 10-Year P/B Range
Min: 1.01   Max: 5.24
Current: 2.4

1.01
5.24
P/S 0.90
UHS's P/S is ranked higher than
53% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 0.81 vs. UHS: 0.90 )
UHS' s 10-Year P/S Range
Min: 0.33   Max: 1.61
Current: 0.9

0.33
1.61
PFCF 15.00
UHS's PFCF is ranked lower than
51% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 14.34 vs. UHS: 15.00 )
UHS' s 10-Year PFCF Range
Min: 8.13   Max: 333.88
Current: 15

8.13
333.88
EV-to-EBIT 11.2
UHS's EV-to-EBIT is ranked higher than
95% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 13.20 vs. UHS: 11.2 )
UHS' s 10-Year EV-to-EBIT Range
Min: 6.1   Max: 21.7
Current: 11.2

6.1
21.7
PEG 0.7
UHS's PEG is ranked higher than
97% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. UHS: 0.7 )
UHS' s 10-Year PEG Range
Min: 0.41   Max: 3.44
Current: 0.7

0.41
3.44
Shiller P/E 21.4
UHS's Shiller P/E is ranked higher than
78% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 11.50 vs. UHS: 21.4 )
UHS' s 10-Year Shiller P/E Range
Min: 8.28   Max: 26.74
Current: 21.4

8.28
26.74

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.30
UHS's Dividend Yield is ranked higher than
60% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 1.85 vs. UHS: 0.30 )
UHS' s 10-Year Dividend Yield Range
Min: 0.14   Max: 0.99
Current: 0.3

0.14
0.99
Dividend Payout 0.1
UHS's Dividend Payout is ranked higher than
99% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 0.75 vs. UHS: 0.1 )
UHS' s 10-Year Dividend Payout Range
Min: 0.03   Max: 0.12
Current: 0.1

0.03
0.12
Dividend growth (3y) 8.4
UHS's Dividend growth (3y) is ranked higher than
93% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: -6.00 vs. UHS: 8.4 )
UHS' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 41.4
Current: 8.4

0
41.4
Yield on cost (5-Year) 0.44
UHS's Yield on cost (5-Year) is ranked higher than
59% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 2.00 vs. UHS: 0.44 )
UHS' s 10-Year Yield on cost (5-Year) Range
Min: 0.21   Max: 1.45
Current: 0.44

0.21
1.45
Share Buyback Rate 0.1
UHS's Share Buyback Rate is ranked higher than
88% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: -0.60 vs. UHS: 0.1 )
UHS' s 10-Year Share Buyback Rate Range
Min: 5.1   Max: -1.2
Current: 0.1

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 8.2
UHS's Price/Net Current Asset Value is ranked higher than
63% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 6.55 vs. UHS: 8.2 )
UHS' s 10-Year Price/Net Current Asset Value Range
Min: 3.9   Max: 12.2
Current: 8.2

3.9
12.2
Price/DCF (Projected) 1.2
UHS's Price/DCF (Projected) is ranked higher than
89% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 0.80 vs. UHS: 1.2 )
UHS' s 10-Year Price/DCF (Projected) Range
Min: 0.8   Max: 1.5
Current: 1.2

0.8
1.5
Price/Median PS Value 1.2
UHS's Price/Median PS Value is ranked higher than
57% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 0.90 vs. UHS: 1.2 )
UHS' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 2.1
Current: 1.2

0.5
2.1
Price/Peter Lynch Fair Value 0.7
UHS's Price/Peter Lynch Fair Value is ranked higher than
89% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. UHS: 0.7 )
UHS' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.5   Max: 2.9
Current: 0.7

0.5
2.9
Earnings Yield (Greenblatt) 8.90
UHS's Earnings Yield (Greenblatt) is ranked lower than
78% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. UHS: 8.90 )
UHS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.6   Max: 16.5
Current: 8.9

4.6
16.5
Forward Rate of Return (Yacktman) 24.39
UHS's Forward Rate of Return (Yacktman) is ranked higher than
84% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 11.99 vs. UHS: 24.39 )
UHS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 7.6   Max: 26.1
Current: 24.39

7.6
26.1

Business Description

Universal Health Services, Inc, is a Delaware corporation organized in 1979. The Company through its subsidiaries is engaged in the business of owning and operating, acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. Services provided by hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and behavioral health services. The Company provides capital resources as well as management services to facilities, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations. The Company's reportable operating segments consist of acute care hospital services and behavioral health care services. The 'Other' segment includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for its other operating entities including outpatient surgery and radiation centers. All of the Company's acute care hospitals and most of its behavioral health centers are certified as providers of Medicare and Medicaid services by the appropriate governmental authorities. Medicare is a federal program that provides certain hospital and medical insurance benefits to persons aged 65 and over, some disabled persons and persons with end-stage renal disease. Medicaid is a joint federal-state funded health care benefit program that is administered by the states to provide benefits to qualifying individuals who are unable to afford care. Most state Medicaid payments are made under a PPS-like system, or under programs that negotiate payment levels with individual hospitals. The Company's hospitals also provide services to individuals covered by private health care insurance. Private insurance carriers typically make direct payments to hospitals or, in some cases, reimburse their policy holders, based upon the particular hospital's established charges and the particular coverage provided in the insurance policy. Its hospitals provide services to individuals that do not have any form of health care coverage. Such patients are evaluated, at the time of service or shortly thereafter, for their ability to pay based upon federal and state poverty guidelines, qualifications for Medicaid or other state assistance programs, as well as its local hospital's indigent and charity care policy. The Company owned and/or operated 25 acute care hospitals and 198 behavioral health centers located in 36 states, Washington, D.C., Puerto Rico and the U.S. Virgin Islands. The Company's competitors include hospitals that are owned by tax-supported governmental agencies or by nonprofit corporations and m
Company Website
SEC Reports
Industry: Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF
Traded in other countries:UHID.USA, UHS.Germany

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial